News

Modular Medical (Nasdaq:MODD) announced that it began converting its manufacturing line to produce next-generation insulin ...
Modular Medical (Nasdaq:MODD) announced that it began converting its manufacturing line to produce next-generation insulin ...
President Joe Biden traveled to Syracuse, N.Y., on Thursday -- home of his law school alma mater, Syracuse University -- to announce $6.1 billion in federal funding for Micron Technology to boost ...
Scientists found that metformin acts in the brain through Rap1 to control blood sugar. This insight could lead to more precise diabetes treatments. Metformin has been the standard treatment for type 2 ...
In a trial, a daily GLP-1 pill from Eli Lilly delivered "significant weight loss" and "meaningful" A1C reductions for patients with Type 2 diabetes, the pharmaceutical company says.